Monsanto to sales and distribution facilities in 51 countries. In 2005, it finalized the purchase of Seminis Inc, a leading global vegetable and fruit seed company, for $1.4 billion. This made it the world's largest conventional seed company. In 1999 Monsanto sold off NutraSweet Co. In December of the same year, Monsanto agreed to merge with Pharmacia & Upjohn, in a deal valuing the transaction at $27 billion. The agricultural division became a wholly owned subsidiary of the "new" Pharmacia; Monsanto's medical research division, which included products such as Celebrex. In 2000: Pharmacia spun off its agro-biotech subsidiary into a new
Monsanto legal cases Columbia, thereby indicating that Monsanto had complied fully with the terms of the agreement. In 2014, Monsanto reached a settlement with soft wheat farmers over the 2013 discovery of experimental glyphosate-resistant wheat in a field in Oregon which had led to South Korea and Japan temporarily stopping some US wheat importation. The settlement included the establishment of a $2.125 million fund for economically affected soft-wheat farmers. In 2003, Monsanto sued Oakhurst Dairy over Oakhurst's label on its milk cartons that said "Our farmer's pledge: no artificial hormones," referring to the use of bovine somatotropin (rBST). Monsanto argued that the label